iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 5 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

1
Player Avatar FoolNMe2 (35.64) Submitted: 5/19/2011 6:11:54 PM : Outperform Start Price: $1.09 ICAD Score: -55.92

Cancer diagnostic tools assist with elimination of subjective radiologist evaluations by providing quantitative evaluations of radiographs. Joined with GE going into China. Added a breast diagnositic tool to next upgrade.

Featured Broker Partners


Advertisement